Gender |
|
|
Male |
50.0% |
12/24 |
Female |
50.0% |
12/24 |
Indifferent |
0% |
0/24 |
Unknown |
0% |
0/24 |
General |
|
|
Birth Length abnormalities |
0% |
0/5 |
Birth Weight abnormalities |
0% |
0/6 |
Birth Head circumference abnormalities |
0% |
0/2 |
Current Height abnormalities |
28.6% |
4/14 |
< P3 : Short stature |
28.6% |
4/14 |
Current Weight abnormalities |
33.3% |
1/3 |
< P3 : Decreased body weight |
33.3% |
1/3 |
Current Head circumference abnormalities |
40.0% |
2/5 |
< P3 : Microcephaly |
40.0% |
2/5 |
Neurology |
|
|
Neurological abnormalities |
50.0% |
12/24 |
Generalized hypotonia |
37.5% |
9/24 |
Global developmental delay |
8.3% |
2/24 |
Clumsiness |
4.2% |
1/24 |
Febrile seizures |
4.2% |
1/24 |
Neonatal hypotonia |
4.2% |
1/24 |
Behavioral problems |
20.8% |
5/24 |
Anxiety |
12.5% |
3/24 |
Behavioral abnormality |
4.2% |
1/24 |
Hyperactivity |
4.2% |
1/24 |
Shyness |
4.2% |
1/24 |
Facial abnormalities |
|
|
Abnormality of the ear |
76.2% |
16/21 |
Posteriorly rotated ears |
14.3% |
3/21 |
Aplasia/Hypoplasia of the ear |
9.5% |
2/21 |
Protruding ear |
9.5% |
2/21 |
Absent earlobe |
4.8% |
1/21 |
Low-set, posteriorly rotated ears |
4.8% |
1/21 |
Low-set ears |
4.8% |
1/21 |
Macrotia |
4.8% |
1/21 |
Overfolded helix |
4.8% |
1/21 |
Preauricular skin tag |
4.8% |
1/21 |
Stenosis of the external auditory canal |
4.8% |
1/21 |
Abnormality of the eye |
68.2% |
15/22 |
Almond-shaped palpebral fissure |
22.7% |
5/22 |
Hypertelorism |
22.7% |
5/22 |
Downslanted palpebral fissures |
13.6% |
3/22 |
Strabismus |
13.6% |
3/22 |
Ptosis |
9.1% |
2/22 |
Upslanted palpebral fissure |
9.1% |
2/22 |
Abnormality of the lacrimal duct |
4.5% |
1/22 |
Abnormality of the nasolacrimal system |
4.5% |
1/22 |
Abnormality of the eyelid |
4.5% |
1/22 |
Epicanthus |
4.5% |
1/22 |
Hypoplasia of the iris |
4.5% |
1/22 |
Hypoplasia of eyelid |
4.5% |
1/22 |
Iris coloboma |
4.5% |
1/22 |
Long eyelashes |
4.5% |
1/22 |
Prominent epicanthal folds |
4.5% |
1/22 |
Abnormality of the nose |
81.0% |
17/21 |
Prominent nasal bridge |
28.6% |
6/21 |
Abnormality of the nasal alae |
23.8% |
5/21 |
Long nose |
23.8% |
5/21 |
Prominent nose |
19.0% |
4/21 |
Underdeveloped nasal alae |
19.0% |
4/21 |
Wide nasal bridge |
19.0% |
4/21 |
Narrow nose |
14.3% |
3/21 |
Prominent nasal tip |
14.3% |
3/21 |
Abnormality of the nasal tip |
9.5% |
2/21 |
Wide nasal base |
9.5% |
2/21 |
Abnormality of the external nose |
4.8% |
1/21 |
Bilateral choanal atresia |
4.8% |
1/21 |
Pear-shaped nose |
4.8% |
1/21 |
Thick nasal alae |
4.8% |
1/21 |
Abnormality of the mouth |
90.9% |
20/22 |
Cleft palate |
40.9% |
9/22 |
Velopharyngeal insufficiency |
36.4% |
8/22 |
High palate |
13.6% |
3/22 |
Thin upper lip vermilion |
13.6% |
3/22 |
Long philtrum |
9.1% |
2/22 |
Narrow mouth |
9.1% |
2/22 |
Bifid uvula |
4.5% |
1/22 |
Broad alveolar ridges |
4.5% |
1/22 |
Deep philtrum |
4.5% |
1/22 |
High, narrow palate |
4.5% |
1/22 |
Hypoplastic philtrum |
4.5% |
1/22 |
Open mouth |
4.5% |
1/22 |
Short upper lip |
4.5% |
1/22 |
Short philtrum |
4.5% |
1/22 |
Smooth philtrum |
4.5% |
1/22 |
Submucous cleft soft palate |
4.5% |
1/22 |
Visual and hearing impairments |
|
|
Abnormal hearing |
8.7% |
2/23 |
Conductive hearing impairment |
4.3% |
1/23 |
Mild hearing impairment |
4.3% |
1/23 |
Abnormal vision |
21.7% |
5/23 |
Hypermetropia |
8.7% |
2/23 |
Myopia |
4.3% |
1/23 |
Visual impairment |
4.3% |
1/23 |
Heart |
|
|
Abnormality of the heart |
50.0% |
12/24 |
Ventricular septal defect |
25.0% |
6/24 |
Atria septal defect |
8.3% |
2/24 |
Patent ductus arteriosus |
8.3% |
2/24 |
Tetralogy of Fallot |
8.3% |
2/24 |
Abnormality of the aorta |
4.2% |
1/24 |
Interrupted aortic arch |
4.2% |
1/24 |
Interrupted aortic arch type B |
4.2% |
1/24 |
Left-to-right shunt |
4.2% |
1/24 |
Mitral regurgitation |
4.2% |
1/24 |
Muscular ventricular septal defect |
4.2% |
1/24 |
Patent ductus arteriosus after birth at term |
4.2% |
1/24 |
Patent foramen ovale |
4.2% |
1/24 |
Perimembranous ventricular septal defect |
4.2% |
1/24 |
Peripheral pulmonary artery stenosis |
4.2% |
1/24 |
Pulmonic stenosis |
4.2% |
1/24 |
Pulmonary hypertension |
4.2% |
1/24 |
Right aortic arch |
4.2% |
1/24 |
Secundum atrial septal defect |
4.2% |
1/24 |
Gastrointestinal |
|
|
Gastrointestinal abnormalities |
20.8% |
5/24 |
Feeding difficulties |
8.3% |
2/24 |
Inguinal hernia |
8.3% |
2/24 |
Nasal regurgitation |
8.3% |
2/24 |
Umbilical hernia |
4.2% |
1/24 |
Urogenital |
|
|
Abnormality of the urogenital system |
8.3% |
2/24 |
Cryptorchidism |
4.2% |
1/24 |
Ectopic kidney |
4.2% |
1/24 |
Skeleton |
|
|
Skeletal abnormalities |
58.3% |
14/24 |
Micrognathia |
20.8% |
5/24 |
Hypoplasia of the maxilla |
12.5% |
3/24 |
Long fingers |
12.5% |
3/24 |
Retrognathia |
12.5% |
3/24 |
Abnormality of the skull |
8.3% |
2/24 |
Abnormality of the skeletal system |
8.3% |
2/24 |
Malar flattening |
8.3% |
2/24 |
Talipes equinovarus |
8.3% |
2/24 |
Abnormality of the hand |
4.2% |
1/24 |
Abnormality of the distal phalanx of finger |
4.2% |
1/24 |
Dolichocephaly |
4.2% |
1/24 |
Long foot |
4.2% |
1/24 |
Narrow palm |
4.2% |
1/24 |
Overlapping toe |
4.2% |
1/24 |
Scoliosis |
4.2% |
1/24 |
Slender finger |
4.2% |
1/24 |
Small anterior fontanelle |
4.2% |
1/24 |
Small hand |
4.2% |
1/24 |
Skin / Hair / Nails |
|
|
Abnormality of the skin/hair/nails |
25.0% |
6/24 |
Carious teeth |
12.5% |
3/24 |
Abnormality of the scalp hair |
4.2% |
1/24 |
Bilateral single transverse palmar creases |
4.2% |
1/24 |
Cyanosis |
4.2% |
1/24 |
Hypertrichosis |
4.2% |
1/24 |
Hyperhidrosis |
4.2% |
1/24 |
Misalignment of teeth |
4.2% |
1/24 |
Sacral dimple |
4.2% |
1/24 |
Synophrys |
4.2% |
1/24 |
Endocrine / Immunological / Metabolic |
|
|
Abnormality of the endocrine system |
12.5% |
3/24 |
Aplasia of the thymus |
4.2% |
1/24 |
Hypoparathyroidism |
4.2% |
1/24 |
Hypothyroidism |
4.2% |
1/24 |
Abnormality of the metabolic system |
20.8% |
5/24 |
Hypocalcemia |
20.8% |
5/24 |
Abnormality of the immune system |
45.8% |
11/24 |
Recurrent infections |
20.8% |
5/24 |
Abnormality of T cell number |
8.3% |
2/24 |
Recurrent respiratory infections |
8.3% |
2/24 |
Decreased number of CD8+ T cells |
4.2% |
1/24 |